We use cookies on this site to enable your digital experience. By continuing to use this site, you are agreeing to our cookie policy. close

Hypertension Drug's Labeling Problems Prompt GSK Recall

Law360, New York (February 24, 2012, 9:25 PM EST) -- GlaxoSmithKline PLC will recall some 394,000 bottles of a blood-pressure medication in the U.S. after drug labeling problems were revealed at a Novartis AG plant in Nebraska that supplies the medication,...
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.